RxDoctor Payments Data

Aco Jovanov, MD

Family Medicine · Dayton, OHNPI 1639179856

Payments from drug & device makers

$285in general payments, 2019–2025

Across 18 payments — averaging $15.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Xeris Pharmaceuticals, Inc.$47
  • Novo Nordisk$45
  • Otsuka America Pharmaceutical, Inc.$37
  • AbbVie$35
  • Bayer$20
  • Pfizer$18
  • plus $83 from 6 others

What the payments were for

  • Food & beverage$26593%
  • Education$207%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$285 in reported general payments places this provider in the 40th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$40,524
Medicare patients
168
Services billed
455

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide38$52,826
EliquisApixaban44$48,368
Tresiba Flextouch U-200Insulin Degludec12$29,780
XareltoRivaroxaban20$20,554
JardianceEmpagliflozin27$20,332
Lantus SolostarInsulin Glargine,hum.Rec.Anlog104$20,180
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$17,747
Humalog Kwikpen U-100Insulin Lispro46$14,090
TrulicityDulaglutide11$12,486
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$7,614
JanuviaSitagliptin Phosphate11$6,241
Novolog FlexpenInsulin Aspart13$6,144
Levemir FlexpenInsulin Detemir19$6,126
SymbicortBudesonide/Formoterol Fumarate16$5,297
Insulin Lispro Kwikpen U-100Insulin Lispro26$3,923

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$45$52,82638 claims
PfizerEliquis$18$48,36844 claims
GSKTrelegy Ellipta$14$17,74718 claims
AstraZenecaBreztri Aerosphere, Symbicort$12$12,91128 claims
Lilly USA, LLCTrulicity$14$12,48611 claims
AbbVieSynthroid$35$1,91841 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Dayton

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →